Literature DB >> 27193492

Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.

Xiaoguang Li1, Hua Qian1, Ryosuke Sogame1, Yoshiaki Hirako2, Daisuke Tsuruta1, Norito Ishii1, Hiroshi Koga1, Atsunari Tsuchisaka1, Zhexiong Jin1, Kazuo Tsubota3, Akiko Fukumoto4, Chie Sotozono4, Shigeru Kinoshita4, Takashi Hashimoto1.   

Abstract

Previous studies of ocular mucous membrane pemphigoid (OMMP) have identified several components of the basement membrane zone to be autoantigens, including integrin β4. However, there are no extensive or definitive reported studies that address this, particularly in pure OMMP. To clarify the major autoantigens in pure OMMP. In this study, we examined sera from 43 pure OMMP patients for both IgG and IgA antibodies using newly developed immunoblotting analyses with a hemidesmosome-rich fraction and various recombinant proteins of integrin α6β4, in addition to our routine immune-serological tests. Using a hemidesmosome-rich fraction, sera from patients with pure OMMP demonstrated reactivity of IgG and/or IgA antibodies to integrin β4, BP180 and laminin-332. The reactivity of pure OMMP sera to integrin β4 was further confirmed by immunoblotting using integrin β4 recombinant proteins. Using concentrated supernatant of HaCaT cells, only one serum sample showed positive IgG and IgA reactivity to LAD-1, the ectodomain of BP180. None of the pure OMMP sera reacted with any autoantigens on immunoblotting using normal human epidermal or dermal extracts, or purified human laminin-332. Integrin β4 was considered to be the major and specific autoantigen for pure OMMP. The new methods established in this study are useful for detection of various autoantigens, particularly integrin β4.

Entities:  

Keywords:  autoantibody; autoantigen; hemidesmosome-rich fraction; integrin α6β4; pure ocular mucous membrane pemphigoid

Mesh:

Substances:

Year:  2016        PMID: 27193492     DOI: 10.1684/ejd.2016.2772

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  9 in total

Review 1.  [Involvement of mucous membranes in autoimmune bullous diseases].

Authors:  C Günther
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

2.  Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.

Authors:  Wenjing Kuang; Hua Qian; Qiyue Zhang; Wei Li; Takashi Hashimoto; Xin Zeng; Xiaoguang Li
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  Laminins in an in vitro anterior lens capsule model established using HLE B-3 cells.

Authors:  Yu Yan; Hua Qian; Hongda Jiang; Haiyang Yu; Liyao Sun; Xi Wei; Yunduan Sun; Hongyan Ge; Haizhou Zhou; Xiaoguang Li; Takashi Hashimoto; Xianling Tang; Ping Liu
Journal:  Mol Med Rep       Date:  2018-02-08       Impact factor: 2.952

Review 4.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 5.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

6.  Case Report: Variety of Target Antigens During 1 Year Follow-Up of a Patient Initially Diagnosed With Bullous Pemphigoid.

Authors:  Hua Qian; Zhijun Zhou; Luhuai Shi; Huicheng Li; Weijun Liu; Yong Ai; Yangmin Gao; Suying Feng; Takashi Hashimoto; Xiaoguang Li
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

Review 7.  Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.

Authors:  Zhiliang Li; Ke Jing; Suo Li; Suying Feng
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

8.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

9.  European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Authors:  E Schmidt; H Rashid; A V Marzano; A Lamberts; G Di Zenzo; G F H Diercks; S Alberti-Violetti; R J Barry; L Borradori; M Caproni; B Carey; M Carrozzo; G Cianchini; A Corrà; F G Dikkers; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; S Rauz; B D van Rhijn; M Roth; J Setterfield; D Zillikens; G Zambruno; B Horváth; F Caux
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.